| Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 M Bahlo, DR Booth, SA Broadley, MA Brown, SJ Foote, LR Griffiths, ... Nature Genetics 41 (7), 824-828, 2009 | 533 | 2009 |
| Sun exposure and vitamin D are independent risk factors for CNS demyelination RM Lucas, AL Ponsonby, K Dear, PC Valery, MP Pender, BV Taylor, ... Neurology 76 (6), 540-548, 2011 | 475 | 2011 |
| Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci NA Patsopoulos, ... Annals of neurology 70 (6), 897-912, 2011 | 360 | 2011 |
| Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases MP Pender Trends in immunology 24 (11), 584-588, 2003 | 355 | 2003 |
| Apoptosis in the nervous system in experimental allergic encephalomyelitis MP Pender, KB Nguyen, PA McCombe, JFR Kerr Journal of the neurological sciences 104 (1), 81-87, 1991 | 272 | 1991 |
| CD8+ T-cell deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis MP Pender Autoimmune diseases 2012, 2012 | 269 | 2012 |
| Epstein–Barr virus in multiple sclerosis: theory and emerging immunotherapies A Bar-Or, MP Pender, R Khanna, L Steinman, HP Hartung, T Maniar, ... Trends in molecular medicine 26 (3), 296-310, 2020 | 259 | 2020 |
| Immunology of multiple sclerosis MP Pender, JM Greer Current allergy and asthma reports 7 (4), 285-292, 2007 | 230 | 2007 |
| Immune dysregulation and self-reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis? AL Jones, BJ Mowry, MP Pender, JM Greer Immunology and Cell biology 83 (1), 9-17, 2005 | 202 | 2005 |
| The essential role of Epstein-Barr Virus in the pathogenesis of multiple sclerosis MP Pender The Neuroscientist 17 (4), 351-367, 2011 | 195 | 2011 |
| Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population L Tajouri, M Ovcaric, R Curtain, MP Johnson, LR Griffiths, P Csurhes, ... Journal of neurogenetics 19 (1), 25-38, 2005 | 181 | 2005 |
| Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis BT Sadatipour, JM Greer, MP Pender Annals of Neurology: Official Journal of the American Neurological …, 1998 | 181 | 1998 |
| Apoptosis of inflammatory cells in immune control of the nervous system: role of glia MP Pender, MJ Rist Glia 36 (2), 137-144, 2001 | 180 | 2001 |
| Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune Study AL Ponsonby, RM Lucas, IA Van Der Mei, K Dear, PC Valery, MP Pender, ... Neurology 78 (12), 867-874, 2012 | 171 | 2012 |
| Epstein–Barr virus and multiple sclerosis RM Lucas, AM Hughes, MLJ Lay, AL Ponsonby, DE Dwyer, BV Taylor, ... Journal of Neurology, Neurosurgery & Psychiatry 82 (10), 1142-1148, 2011 | 162 | 2011 |
| Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy MP Pender, SR Burrows Clinical & translational immunology 3 (10), e27, 2014 | 159 | 2014 |
| Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis MP Pender, PA Csurhes, C Smith, NL Douglas, MA Neller, KK Matthews, ... JCI insight 3 (22), 2018 | 141 | 2018 |
| Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis MP Pender The Lancet 351 (9107), 978-981, 1998 | 141 | 1998 |
| Defective T‐cell control of Epstein–Barr virus infection in multiple sclerosis MP Pender, PA Csurhes, JM Burrows, SR Burrows Clinical & translational immunology 6 (1), e126, 2017 | 132 | 2017 |
| Apoptosis of [alpha][beta] T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: Its possible implications for recovery and acquired tolerance MP Pender, PA McCombe, G Yoong, KB Nguyen Journal of autoimmunity 5 (4), 401-410, 1992 | 131 | 1992 |
